Summary
Serum concentrations of erythropoietin (EPO) were determined by immunoassay in 45 patients with thalassemia intermedia (TI). The mean serum level of EPO was significantly higher in the thalassemic patients than in the controls, but transfused subjects had lower pretransfusional serum concentrations of EPO than untransfused ones. An inverse relationship between the serum values of EPO and total hemoglobin was observed only in the untransfused thalassemic patients. These data suggest that in TI, even a low transfusional regimen may cause a decrease in serum concentration of EPO, independent of the level of total Hb.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sherwood JB, Goldwasser E, Chilcote R, Charmichael LD, Nagel RL (1986) Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood 67:46–49
Manor D, Fibach E, Goldfarb A, Rachmilewitz EA (1986) Erythropoietin activity in the serum of beta-thalassemic patients. Scand J Haematol 37:221–228
Alessi M, Longo G, Di Martino G, Cacciola E jr, Sortino G (1990) Erythropoietin serum levels in beta-thalassemia. Ann NY Acad Sci 6:534–536
Vedovato M, Salvatorelli G, Balboni GC, Taddei Maseri M, Dolcini B, Toffoli C (1986) Erythropoietin levels in heterozygous alpha-thalassemia. Acta Haematol 76:159–160
Vedovato M, Salvatorelli G, Vullo C, Taddei Masieri M, Balboni GC (1984) Erythropoietin levels in heterozygous betathalassemia. Acta Haematol 71:211–213
Modell B, Berdoukas V (1984) The clinical approach to thalassemia. Grune & Stratton, London, p 242
Singer K, Chernoff AC, Singer L (1951) Studies on abnormal hemoglobins. Their denaturation in sickle cell anemia and hematological disorders by means of alkali denaturation. Blood 6:413–422
André M, Bergmann P, Ferster A, Toppet M, Fondu P (1991) Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia. Nouv Rev Fr Hematol 33:299–302
Rachmilewitz EA, Goldfarb A, Dover G (1991) Administration of erythropoietin to patients with β-thalassemia intermedia: a preliminary trial. Blood 78:1145–1147
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dore, F., Bonfigli, S., Gaviano, E. et al. Serum erythropoietin levels in thalassemia intermedia. Ann Hematol 67, 183–186 (1993). https://doi.org/10.1007/BF01695865
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01695865